Form 4 for RVMD Revolution Medicines, Inc.
Accepted 2026-03-03 00:00:00 ET · period of report 2026-03-01 · accession 0001610717-26-000085 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-01 | RVMD | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +15.1K | 118.1K | +15% | $0 |
| D | 2026-03-03 | 2026-03-01 | RVMD | Wang Xiaolin | See Remarks | A - Grant | $0.00 | +34.0K | 34.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-01 | A | A | 15,100 | $0.00 | 118,073 | D | — | — | (F1) Includes 54,464 restricted stock units. (F2) Includes 652 shares acquired under the Issuer's Employee Stock Purchase Plan on May 31, 2025. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-03-01 | A | A | 34,000 | $0.00 | 34,000 | D | $102.02 · — to 2036-02-28 | 34,000 Common Stock | (F3) One forty-eighth (1/48th) of the shares initially subject to the option will vest on each monthly anniversary measured from March 1, 2026 (the "Vesting Commencement Date"), so that 100% of the shares subject to the option will be fully vested and exercisable as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service through each vesting date. |